These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

736 related articles for article (PubMed ID: 25687026)

  • 1. Aqueous Levels of Angiopoietin-like 4 and Semaphorin 3E Correlate with Nonperfusion Area and Macular Volume in Diabetic Retinopathy.
    Kwon SH; Shin JP; Kim IT; Park DH
    Ophthalmology; 2015 May; 122(5):968-75. PubMed ID: 25687026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aqueous Angiopoietin-Like 4 Levels Correlate With Nonperfusion Area and Macular Edema in Branch Retinal Vein Occlusion.
    Kim JH; Shin JP; Kim IT; Park DH
    Invest Ophthalmol Vis Sci; 2016 Jan; 57(1):6-11. PubMed ID: 26746013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Plasma Semaphorin 3A With Phenotypes of Diabetic Retinopathy and Nephropathy.
    Kwon SH; Shin JP; Kim IT; Park DH
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):2983-9. PubMed ID: 27273597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aqueous humour levels of vascular endothelial growth factor and erythropoietin in patients with diabetic macular oedema before and after intravitreal erythropoietin injection.
    Lim JW; Han JR
    Clin Exp Ophthalmol; 2011 Aug; 39(6):537-44. PubMed ID: 21819507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Re: Kwon et al.: Aqueous levels of angiopoietin-like 4 and semaphorin 3E correlate with nonperfusion area and macular volume in diabetic retinopathy (Ophthalmology 2015;122:968-75).
    Sodhi A; Montaner S
    Ophthalmology; 2016 Jan; 123(1):e7-8. PubMed ID: 26707445
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
    Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
    JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinate increases in the vitreous fluid of patients with active proliferative diabetic retinopathy.
    Matsumoto M; Suzuma K; Maki T; Kinoshita H; Tsuiki E; Fujikawa A; Kitaoka T
    Am J Ophthalmol; 2012 May; 153(5):896-902.e1. PubMed ID: 22265145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor in aqueous humor before and after intravitreal injection of bevacizumab in eyes with diabetic retinopathy.
    Sawada O; Kawamura H; Kakinoki M; Sawada T; Ohji M
    Arch Ophthalmol; 2007 Oct; 125(10):1363-6. PubMed ID: 17923544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitreous mediators after intravitreal bevacizumab or triamcinolone acetonide in eyes with proliferative diabetic retinopathy.
    Arimura N; Otsuka H; Yamakiri K; Sonoda Y; Nakao S; Noda Y; Hashiguchi T; Maruyama I; Sakamoto T
    Ophthalmology; 2009 May; 116(5):921-6. PubMed ID: 19410951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aqueous Level of ANGPTL4 Correlates with the OCTA Metrics of Diabetic Macular Edema in NPDR.
    Xu Q; Gong C; Qiao L; Feng R; Liu H; Liu Y; Ji S; Zhang Y; Wu S; Li S
    J Diabetes Res; 2022; 2022():8435603. PubMed ID: 35097131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of therapy with ranibizumab on diabetic retinopathy severity and baseline risk factors for worsening retinopathy.
    Ip MS; Domalpally A; Sun JK; Ehrlich JS
    Ophthalmology; 2015 Feb; 122(2):367-74. PubMed ID: 25439595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Nonperfusion Area on Ultra-widefield Fluorescein Angiography in Eyes With Diabetic Macular Edema: DAVE Study.
    Fan W; Wang K; Ghasemi Falavarjani K; Sagong M; Uji A; Ip M; Wykoff CC; Brown DM; van Hemert J; Sadda SR
    Am J Ophthalmol; 2017 Aug; 180():110-116. PubMed ID: 28579062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for diabetic macular edema associated with severe capillary loss: one-year results of a pilot study.
    Bonini-Filho M; Costa RA; Calucci D; Jorge R; Melo LA; Scott IU
    Am J Ophthalmol; 2009 Jun; 147(6):1022-30, 1030.e1-5. PubMed ID: 19327746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography.
    Silva PS; Dela Cruz AJ; Ledesma MG; van Hemert J; Radwan A; Cavallerano JD; Aiello LM; Sun JK; Aiello LP
    Ophthalmology; 2015 Dec; 122(12):2465-72. PubMed ID: 26350546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in dose of intravitreous bevacizumab before vitrectomy for proliferative diabetic retinopathy.
    Yamaji H; Shiraga F; Shiragami C; Nomoto H; Fujita T; Fukuda K
    Arch Ophthalmol; 2011 Jan; 129(1):106-7. PubMed ID: 21220639
    [No Abstract]   [Full Text] [Related]  

  • 16. Optical coherence tomography angiography analysis of macular vessel density before and after anti-VEGF therapy in eyes with diabetic retinopathy.
    Sorour OA; Sabrosa AS; Yasin Alibhai A; Arya M; Ishibazawa A; Witkin AJ; Baumal CR; Duker JS; Waheed NK
    Int Ophthalmol; 2019 Oct; 39(10):2361-2371. PubMed ID: 31119505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy.
    Babapoor-Farrokhran S; Jee K; Puchner B; Hassan SJ; Xin X; Rodrigues M; Kashiwabuchi F; Ma T; Hu K; Deshpande M; Daoud Y; Solomon S; Wenick A; Lutty GA; Semenza GL; Montaner S; Sodhi A
    Proc Natl Acad Sci U S A; 2015 Jun; 112(23):E3030-9. PubMed ID: 26039997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor in plasma and vitreous fluid of patients with proliferative diabetic retinopathy patients after intravitreal injection of bevacizumab.
    Ma Y; Zhang Y; Zhao T; Jiang YR
    Am J Ophthalmol; 2012 Feb; 153(2):307-313.e2. PubMed ID: 21982107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in aqueous concentrations of various cytokines after intravitreal triamcinolone versus bevacizumab for diabetic macular edema.
    Sohn HJ; Han DH; Kim IT; Oh IK; Kim KH; Lee DY; Nam DH
    Am J Ophthalmol; 2011 Oct; 152(4):686-94. PubMed ID: 21782151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.